The effectiveness of physiotherapy exercises in subacromial impingement syndrome: a systematic review and meta-analysis

CE Hanratty, JG McVeigh, DP Kerr, JR Basford… - Seminars in arthritis and …, 2012 - Elsevier
OBJECTIVE: To evaluate the effectiveness of exercise in the treatment of people with
subacromial impingement syndrome (SAIS). METHODS: A systematic review and meta-analysis …

Physical therapists' perceptions and use of exercise in the management of subacromial shoulder impingement syndrome: focus group study

CE Hanratty, DP Kerr, IM Wilson, M McCracken… - Physical …, 2016 - academic.oup.com
… In a recent systematic review and meta-analysis of 16 RCTs, Hanratty et al 13 concluded that
… Dr Hanratty, Mr Kerr, and Dr McVeigh provided project management. Dr Hanratty provided …

[HTML][HTML] Factors affecting adherence with treatment advice in a clinical trial of patients with severe asthma

…, DC Cowan, R Djukanovic, CE Hanratty… - European …, 2022 - Eur Respiratory Soc
Background Understanding why patients with severe asthma do not follow healthcare
provider (HCP) advice to adjust treatment is critical to achieving personalised disease …

[HTML][HTML] Composite type-2 biomarker strategy versus a symptom–risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre …

LG Heaney, J Busby, CE Hanratty… - The Lancet …, 2021 - thelancet.com
Background Asthma treatment guidelines recommend increasing corticosteroid dose to
control symptoms and reduce exacerbations. This approach is potentially flawed because …

[HTML][HTML] An investigation into the use of mHealth in musculoskeletal physiotherapy: Scoping review

JMR Agnew, CE Hanratty, JG McVeigh… - JMIR rehabilitation …, 2022 - rehab.jmir.org
Background Musculoskeletal physiotherapy provides conservative management for a range
of conditions. Currently, there is a lack of engagement with exercise programs because of …

Exacerbation profile and risk factors in a type-2–low enriched severe asthma cohort: a clinical trial to assess asthma exacerbation phenotypes

PJ McDowell, J Busby, CE Hanratty… - American journal of …, 2022 - atsjournals.org
Rationale: The past 25 years have seen huge progress in understanding of the pathobiology
of type-2 (T2) asthma, identification of measurable biomarkers, and the emergence of novel …

[HTML][HTML] A randomized trial of a composite T2-biomarker strategy adjusting corticosteroid treatment in severe asthma: a post hoc analysis by sex

…, J Busby, DJ Jackson, ID Pavord, CE Hanratty… - The Journal of Allergy …, 2023 - Elsevier
Background Approximately 5% to 10% of patients with asthma have severe disease, with a
consistent preponderance in females. Current asthma guidelines recommend stepwise …

[HTML][HTML] A randomised pragmatic trial of corticosteroid optimization in severe asthma using a composite biomarker algorithm to adjust corticosteroid dose versus …

CE Hanratty, JG Matthews, JR Arron, DF Choy… - Trials, 2018 - Springer
Background Patients with difficult-to-control asthma consume 50–60% of healthcare costs
attributed to asthma and cost approximately five-times more than patients with mild stable …

[HTML][HTML] Rating the quality of smartphone apps related to shoulder pain: systematic search and evaluation using the Mobile App Rating Scale

JMR Agnew, C Nugent, CE Hanratty… - JMIR Formative …, 2022 - formative.jmir.org
Background: The successful rehabilitation of musculoskeletal pain requires more than medical
input alone. Conservative treatment, including physiotherapy and exercise therapy, can …

[HTML][HTML] Utility of fractional exhaled nitric oxide suppression as a prediction tool for progression to biologic therapy

…, J Logan, J Holmes, J Busby, CE Hanratty… - ERJ Open …, 2021 - Eur Respiratory Soc
Rationale: The utility of fractional exhaled nitric oxide (F ENO ) suppression (FeNOSuppT)
to identify non-adherence to inhaled corticosteroid (ICS) treatment has previously been …